Inquirer
GENEVA, Switzerland — The World Health Organization announced Friday that it had given prequalification approval to a malaria treatment for newborns and infants for the first time. Artemether-lumefantrine is the first antimalarial formulation designed specifically for the youngest victims of the mosquito-borne disease. “The prequalification designation indicates that the medicine meets international standards of quality, safety and efficacy,” the WHO said in a statement. READ: WHO endorses first-ever vaccine against malaria Up to now, infants have been treated with formulations intended for older children — carrying a greater risk of dosage errors, side effects and toxicity. “For centuries, malaria has […]... Keep on reading: WHO approves first malaria treatment for infants
Go to News Site